Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence J Appel

Showing results (471-480 of 481) with videos related to

Pageof 49
Sort By:
BMC Health Services Research|May 9, 2025
Disruption to diabetes and hypertension care during the COVID-19 pandemic in Latin America and the Caribbean and mitigation approaches: a scoping reviewOluwabunmi Ogungbe, Samira Barbara Jabakhanji, Roopa Mehta, et al.
Journal of the American Society of Nephrology : JASN|August 7, 2019
<i>APOL1</i> Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-AnalysisMorgan E Grams, Aditya Surapaneni, Shoshana H Ballew, et al.
The New England Journal of Medicine|September 8, 2010
Intensive blood-pressure control in hypertensive chronic kidney diseaseLawrence J Appel, Jackson T Wright, Tom Greene, et al.
Plos Medicine|November 18, 2025
Association between cigarette smoking status, intensity, and cessation duration with long-term incidence of nine cardiovascular and mortality outcomes: The Cross-Cohort Collaboration (CCC)Erfan Tasdighi, Zhiqi Yao, Zeina A Dardari, et al.
Circulation|February 12, 2026
Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort CollaborationZeina A Dardari, Zhiqi Yao, Jianjun Zhang, et al.
Journal of the American College of Cardiology|March 12, 2025
Association Between Cigarette Smoking and Subclinical Markers of Cardiovascular HarmZhiqi Yao, Erfan Tasdighi, Zeina A Dardari, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
JAMA|October 3, 2023
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis, Morgan E Grams, Josef Coresh, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 49

Showing results (471-480 of 481) with videos related to

Sort By:
Pageof 49
BMC Health Services Research|May 9, 2025
Disruption to diabetes and hypertension care during the COVID-19 pandemic in Latin America and the Caribbean and mitigation approaches: a scoping reviewOluwabunmi Ogungbe, Samira Barbara Jabakhanji, Roopa Mehta, et al.
Journal of the American Society of Nephrology : JASN|August 7, 2019
<i>APOL1</i> Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-AnalysisMorgan E Grams, Aditya Surapaneni, Shoshana H Ballew, et al.
The New England Journal of Medicine|September 8, 2010
Intensive blood-pressure control in hypertensive chronic kidney diseaseLawrence J Appel, Jackson T Wright, Tom Greene, et al.
Plos Medicine|November 18, 2025
Association between cigarette smoking status, intensity, and cessation duration with long-term incidence of nine cardiovascular and mortality outcomes: The Cross-Cohort Collaboration (CCC)Erfan Tasdighi, Zhiqi Yao, Zeina A Dardari, et al.
Circulation|February 12, 2026
Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort CollaborationZeina A Dardari, Zhiqi Yao, Jianjun Zhang, et al.
Journal of the American College of Cardiology|March 12, 2025
Association Between Cigarette Smoking and Subclinical Markers of Cardiovascular HarmZhiqi Yao, Erfan Tasdighi, Zeina A Dardari, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
JAMA|October 3, 2023
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis, Morgan E Grams, Josef Coresh, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 49